心血管病学进展2024,Vol.45Issue(12) :1066-1069.DOI:10.16806/j.cnki.issn.1004-3934.2024.12.003

伊伐布雷定用于心房颤动心室率控制的研究进展

Ivabradine for Heart Rate Control in Atrial Fibrillation

王競婧 姚建晗 黄新苗 郭志福 曹江
心血管病学进展2024,Vol.45Issue(12) :1066-1069.DOI:10.16806/j.cnki.issn.1004-3934.2024.12.003

伊伐布雷定用于心房颤动心室率控制的研究进展

Ivabradine for Heart Rate Control in Atrial Fibrillation

王競婧 1姚建晗 1黄新苗 1郭志福 1曹江1
扫码查看

作者信息

  • 1. 海军军医大学第一附属医院心血管内科,上海 200433
  • 折叠

摘要

控制心室率是心房颤动(AF)治疗的重要方面.目前可用于AF心室率控制的药物受到副作用和疗效的限制.伊伐布雷定通过抑制窦房结funny电流(If),降低窦性心室率.有研究表明,房室结中也存在If通道,阻断房室结If会减慢房室传导,可降低AF的心室率.近期伊伐布雷定用于控制AF心室率治疗引起较多关注.现就伊伐布雷定在AF心室率控制方面的基础和临床研究做一综述.

Abstract

Control of ventricular rate is recommended for patients with atrial fibrillation(AF).Currently available agents for rate control in AF are limited by adverse effects and their ability to attain target heart rate.By inhibiting funny current(If)of the sinoatrial node,ivabradine reduces sinus heart rate.However,it has been shown that If channels can also be found in atrioventricular node and blocking atrioventricular nodal If slows atrioventricular conduction,resulting in lower ventricular rates during AF.Ivabradine has drawn recent interest as a rate control agent for AF.In this review,we focus on the basic and clinical evidence for ventricular rate control of ivabradine in AF.

关键词

心房颤动/funny电流/伊伐布雷定/心室率控制/房室结

Key words

Atrial fibrillation/Funny current/Ivabradine/Heart rate control/Atrioventricular node

引用本文复制引用

出版年

2024
心血管病学进展
成都市心血管病研究所,成都市第三人民医院

心血管病学进展

CSTPCD
影响因子:0.932
ISSN:1004-3934
段落导航相关论文